查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球血管内导管市场
市场调查报告书
商品编码
1255882

2023-2030 年全球血管内导管市场

Global Intravascular Catheters Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球血管内导管市场预计将经历有利可图的增长。

血管内导管是一种细而柔韧的管子，通过皮肤上的小切口插入肾臟的肾盂。 导管用缝合线或胶带固定，并连接到收集尿液的引流袋。 血管内导管可用于短期或长期肾引流，具体取决于患者的情况。

市场动态

全球老年人口不断增长

在世界范围内，人们的寿命越来越长。 现在预计大多数人都可以活到 60 岁以后。 在世界范围内，老年人口的数量和比例都在增加。 根据世界卫生组织的数据，到 2030 年，地球上六分之一的人将超过 60 岁。 届时，60 岁以上的人口将从 2020 年的 10 亿增加到 14 亿。 到 2050 年，地球上 60 岁以上的人口数量将翻一番。 （21 亿人）。 从 2020 年到 2050 年，80 岁及以上的人口数量预计将增加两倍，达到 4.26 亿。 随着老年人口的不断增长，静脉导管的使用在老年人护理中变得越来越重要。 静脉导管通常用于老年患者，以进入血液以给药药物、液体和营养物质。

静脉导管的替代品

静脉导管是现代医学中的重要工具，但有多种替代品可用于类似目的。 这些替代方案包括口服药物、肌肉注射和皮下注射。 这可能会限制对静脉导管的需求，尤其是当这些替代品有效时。 静脉导管的成本可能是一个限制因素，尤其是在资源匮乏的环境中。 静脉导管相对昂贵，如果发生并发症或感染，成本会增加。

COVID-19 影响分析

COVID-19 大流行对血管内导管市场产生了相当大的影响。 一方面，由于疫情期间对医疗器械和耗材的需求增加，部分地区对血管内导管的需求激增。 随着大流行的蔓延，对重症监护服务的需求猛增，例如为需要重症监护的患者使用血管内导管。 因此，对导管的需求增加了，尤其是在一些受疫情影响严重的地区。 为了遏制 COVID-19 的传播，许多医疗保健提供者正在推迟非必要的医疗程序，包括为选择性程序放置血管内导管。

内容

第一章调查方法及范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 按产品分类的片段
  • 使用特定片段
  • 最终用户的片段
  • 区域摘要

第四章市场动态

  • 影响因素
    • 司机
      • 肾衰竭患者人数上升
      • 增加慢性病的患病率
    • 约束因素
      • 血管内留置导管的发病率和死亡率风险
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • 在 COVID-19 情景之前
    • 当前的 COVID-19 情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格波动
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 结论

第 7 章副产品

  • 短 PIVC
  • 集成/封闭式 PIVC

第 8 章应用

  • 肿瘤学
  • 胃肠病学
  • 肾臟疾病
  • 感染
  • 其他

第 9 章最终用户

  • 医院
  • 门诊手术诊所
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 俄罗斯
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 竞争场景
  • 市场分析/份额分析
  • 併购分析

第12章公司简介

  • 欧姆龙公司
    • 公司简介
    • 产品组合和说明
    • 财务摘要
    • 主要发展
  • Koninklijke Philips N.V
  • Cook Medical
  • Allied Healthcare Products, Inc
  • Becton, Dickinson, and Company
  • Agilent Technologies
  • Medline Industries, Inc.
  • Boston Scientific Corporation
  • Johnson & Johnson
  • GF Health Products, Inc

第13章附录

  • 关于我们和我们的服务
  • 联繫我们
简介目录
Product Code: MD1473

Market Overview

The global intravascular catheters market reached US$ XX million in 2022 and is projected to witness lucrative growth by reaching up to US$ XX million by 2030. The market is growing at a CAGR of xx% during the forecast period (2023-2030).

The Intravascular catheter is a thin, flexible tube inserted through a small incision in the skin into the renal pelvis of the kidney. The catheter is secured with a stitch or adhesive tape and connected to a drainage bag, which collects the urine. Intravascular catheters may be used for short-term or long-term kidney drainage, depending on the patient's medical condition.

Market Dynamics

The growing older population worldwide

Globally, people are living longer. Today, the majority of people may anticipate living into their 60s and beyond. The number of older people and their share of the population is increasing in every nation worldwide. Based on WHO data one in six individuals on the planet will be 60 or older by 2030. By this point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of persons in the globe who are 60 years or older will double by 2050. (2.1 billion). Between 2020 and 2050, the number of people 80 or older is projected to treble, reaching 426 million. As the geriatric population continues to grow, the use of IV catheters is becoming increasingly important in the care of older adults. IV catheters are commonly used in geriatric patients to provide access to the bloodstream for the delivery of medications, fluids, and nutrition.

Alternative available for intravenous catheters

Intravenous catheters are an important tool in modern medicine, there are several alternatives available that can be used for similar purposes. These alternatives include oral medications, intramuscular injections, and subcutaneous injections. This can limit the demand for IV catheters, particularly in cases where these alternatives are effective. The cost of IV catheters can be a limiting factor for their use, particularly in resource-limited settings. IV catheters can be relatively expensive, and the cost can increase if complications or infections arise.

COVID-19 Impact Analysis

The COVID-19 pandemic had a considerable impact on the intravascular catheter market. On the one hand, the increased demand for medical devices and supplies during the pandemic has led to a surge in demand for intravascular catheters in certain regions. As the pandemic has spread, there has been a surge in demand for critical care services, including the use of intravascular catheters for patients who require intensive care. This has led to increased demand for catheters in certain regions, particularly those that have been hit hardest by the pandemic. To reduce the spread of COVID-19, many healthcare providers have postponed non-essential medical procedures, including the placement of intravascular catheters for elective procedures.

Segment Analysis

The global intravascular catheter market is segmented based on product, application, and region.

Owing to their versatility, the oncology product

Intravascular catheters are commonly used in oncology for the administration of chemotherapy, as well as for the collection of blood samples for monitoring treatment efficacy and disease progression. Peripherally Inserted Central Catheters (PICCs) are another type of intravascular catheter that is commonly used in oncology. These catheters are typically inserted through a peripheral vein in the arm and are threaded through to the superior vena cava. PICCs provide a less invasive alternative to CVCs and can be used for the administration of chemotherapy drugs, as well as for the collection of blood samples.

Geographical Analysis

The growing demand for healthcare services and the increasing geriatric population

Asia Pacific region has emerged as the dominant market for intravascular catheters in recent years. This can be attributed to several factors, including the growing demand for healthcare services, the increasing prevalence of chronic diseases, and the expanding geriatric population. As healthcare systems in the Asia Pacific region continue to expand and modernize, there has been a growing demand for medical devices and supplies, including intravascular catheters. The Asia Pacific region has witnessed a rapid rise in the prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer. This has led to an increased demand for intravascular catheters for the administration of medication and other treatments.

Competitive Landscape

The major global players in the market include: Omron Corporation, Koninklijke Philips N.V, Cook Medical, Allied Healthcare Products, Inc, Becton, Dickinson and Company, Agilent Technologies, Medline Industries, Inc., Boston Scientific Corporation, Johnson & Johnson, GF Health Products, Inc.

Why Purchase the Report?

  • To visualize the global Intravascular Catheters market segmentation based on product, application, end user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous Intravascular Catheters market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global intravascular catheters market report would provide approximately 61 tables, 58 figures, and 195+ pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Number Of Kidney Failures
      • 4.1.1.2. Increasing Prevalence Of Chronic Diseases
      • 4.1.1.3. XX
    • 4.1.2. Restraints
      • 4.1.2.1. The risk of Morbidity and Mortality Presented by Intravascular Catheters
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
      • 4.1.3.1. XX
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Short PIVC*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Integrated/Closed PIVC

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Oncology*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Gastroenterology
  • 8.4. Renal Disease
  • 8.5. Infectious Diseases
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgery Clinics
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Omron Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Koninklijke Philips N.V
  • 12.3. Cook Medical
  • 12.4. Allied Healthcare Products, Inc
  • 12.5. Becton, Dickinson, and Company
  • 12.6. Agilent Technologies
  • 12.7. Medline Industries, Inc.
  • 12.8. Boston Scientific Corporation
  • 12.9. Johnson & Johnson
  • 12.10. GF Health Products, Inc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us